Diffuse interstitial pneumonia-like/macrophage activation syndrome-like changes in patients with COVID-19 correlate with length of illness

Ann Diagn Pathol. 2021 Aug:53:151744. doi: 10.1016/j.anndiagpath.2021.151744. Epub 2021 Apr 19.

Abstract

Objectives: Assess the pathologic changes in the lungs of COVID-19 decedents and correlate these changes with demographic data, clinical course, therapies, and duration of illness.

Methods: Lungs of 12 consecutive COVID-19 decedents consented for autopsy were evaluated for gross and histopathologic abnormalities. A complete Ghon "en block" dissection was performed on all cases; lung weights and gross characteristics recorded. Immunohistochemical studies were performed to characterize lymphocytic infiltrates and to assess SARS-CoV-2 capsid protein.

Results: Two distinct patterns of pulmonary involvement were identified. Three of 12 cases demonstrated a predominance of acute alveolar damage (DAD) while 9 of 12 cases demonstrated a marked increase in intra-alveolar macrophages in a fashion resembling desquamative interstitial pneumonia or macrophage activation syndrome (DIP/MAS). Two patterns were correlated solely with a statistically significant difference in the duration of illness. The group exhibiting DAD had duration of illness of 5.7 days while the group with DIP/MAS had duration of illness of 21.5 days (t-test p = 0.014).

Conclusions: The pulmonary pathology of COVID-19 patients demonstrates a biphasic pattern, an acute phase demonstrating DAD changes while the patients with a more prolonged course exhibit a different pattern that resembles DIP/MAS-like pattern. The potential mechanisms and clinical significance are discussed.

Keywords: COVID-19; Desquamative interstitial pneumonia-like; Macrophage activation syndrome-like.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Autopsy
  • COVID-19 / complications
  • COVID-19 / diagnosis
  • COVID-19 / pathology*
  • COVID-19 / virology
  • Capsid Proteins / metabolism
  • Comorbidity
  • Female
  • Humans
  • Immunohistochemistry / methods*
  • Lung / metabolism
  • Lung / pathology*
  • Lung Diseases, Interstitial / etiology
  • Lung Diseases, Interstitial / pathology*
  • Lung Diseases, Interstitial / virology
  • Lymphocytes / metabolism
  • Lymphocytes / pathology
  • Macrophage Activation Syndrome / etiology
  • Macrophage Activation Syndrome / pathology*
  • Macrophage Activation Syndrome / virology
  • Macrophages / pathology
  • Male
  • Middle Aged
  • Pulmonary Alveoli / immunology
  • Pulmonary Alveoli / pathology
  • SARS-CoV-2 / genetics
  • Sick Leave

Substances

  • Capsid Proteins